CD44 and neoplasm: Notably, the abundance of CD44+ and CD133+ cells and the expression of EpCAM, Oct4 and CD54 in GC have been correlated with TNM stage, tumor size, lymphovascular and distant metastases, poor prognosis and low survival [19].